1-7 of 7
Martina Jansen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Atenativ, a Plasma-Derived Antithrombin Concentrate, Used in Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Parturition: Study Description (NCT04918173)

Craig M. Kessler, Claudio Sandoval, Martina Jansen, Cristina Solomon, Sigurd Knaub, Michael D Tarantino
Journal: Blood
Blood (2022) 140 (Supplement 1): 8548–8549.
https://doi.org/10.1182/blood-2022-166246
Published: 2022
Journal Articles

Nuwiq Dosing and Outcomes in the Management of Women/Girls with Haemophilia a Needing FVIII Treatment for Surgery - an International, Open-Label, Non-Controlled Study (NuDIMENSION)

Johannes Oldenburg, Natascha Marquardt, Martina Jansen, Sigurd Knaub
Journal: Blood
Blood (2022) 140 (Supplement 1): 11323–11324.
https://doi.org/10.1182/blood-2022-156405
Published: 2022
Journal Articles

Practical Utilisation of Octapharma FVIII Concentrates in Previously Untreated and Minimally Treated Haemophilia a Patients Entering Routine Clinical Treatment with Nuwiq ® , Octanate ® or Wilate ® — the Protect-NOW Study

Johannes Oldenburg, MD PhD, Anna Pavlova, MD PhD, Susan Halimeh, MD, Robert Klamroth, Joris Versteden, Martina Jansen, Larisa Belyanskaya, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5034.
https://doi.org/10.1182/blood-2018-99-116577
Published: 2018
Journal Articles

The PUP-GCP Clinical Trial: A Low Inhibitor Rate in Previously Untreated Patients with Severe Hemophilia a Treated with Octanate

Sigurd Knaub, PhD, Anna Klukowska, MD, Vladimir Komrska, Pawel Laguna, MD PhD, Vdovin Vladimir, MD, Martina Jansen
Journal: Blood
Blood (2014) 124 (21): 5051.
https://doi.org/10.1182/blood.V124.21.5051.5051
Published: 2014
Journal Articles

Efficacy, Immunogenicity, Pharmacokinetics, and Safety Of Human-cl rhFVIII – a GCP Study In Children With Severe Haemophilia A

Raina Liesner, Martina Jansen, Anna Klukowska, Vladimir Vdovin, MD, Tomasz Szczepanski, MD, PHD, Sigurd Knaub, PhD
Journal: Blood
Blood (2013) 122 (21): 3594.
https://doi.org/10.1182/blood.V122.21.3594.3594
Published: 2013
Journal Articles

Latest Results From The PUP-GCP Clinical Trial: A Low Inhibitor Rate In Previously Untreated Patients With Severe Hemophilia A Treated With Octanate

Anna Klukowska, Martina Jansen, Vladimir Komrska, MD, Pawel Laguna, MD, PhD, Vladimir Vdovin, MD, Sigurd Knaub, PhD
Journal: Blood
Blood (2013) 122 (21): 3596.
https://doi.org/10.1182/blood.V122.21.3596.3596
Published: 2013
Journal Articles

Results of a Prospective, Open-Label Trial to Assess the Efficacy, Safety and Immunogenicity of Wilate ® in Children Under 6 Years of Age with Inherited Von Willebrand Disease,

Ulrike Nowak-Gottl, MD, Alexandra Russo, MD, Anne Kruempel, MD, Martina Jansen, Sigurd Knaub, PhD
Journal: Blood
Blood (2011) 118 (21): 3330.
https://doi.org/10.1182/blood.V118.21.3330.3330
Published: 2011